Archive for December 2010
Are stem cells ready as a next generation drug discovery tool?
Posted by: sciclips on: December 17, 2010
This blog analyzes possible limitations of stem cell derived products in drug discovery research and development. We also argue for the need to create a regulatory system for drug screening assays.
Proteomics/Biomarker Patents (12/13/10)
Posted by: sciclips on: December 13, 2010
Highlights of recent proteomics/biomarker patents/patent applications 1. Phosphorylated troponin T as a biomarker for heart failure 2. A computer-implemented method for analyzing biomarkers in patients 3. A method increasing for efficiency of tandem mass spectrometry 4. Ganglioside GM2 Activator Protein (GM2AP) as biomarker for acute renal failure 5. A method of mass spectrometry and a [...]
Stem cell patents (12/7/10)
Posted by: sciclips on: December 8, 2010
Recent stem patents/patent applications highlights: 1. Stem cell-derived cancer cells for the immuno treatment of cancer 2. Stem cell differentiation and moblization by bioelectrical stimulation 3. ECAT11 expression or ECAT11 promoter activity as a marker for selecting clones of iPScells 4. Stem cell based siRNA delivery through gap junctions 5. Stem cell targeting antibodies for [...]
Custom drug discovery data extraction and mining from patents
Posted by: sciclips on: December 2, 2010
SciClips Consultancy provides biological data mining and analysis services to pharmaceutical and biotech companies/research institutes/researchers. SciClips uses its unique technology to extract, analyze and interpret biological information from existing data taken from different sources such as PubMed, US patents, International patent applications (WO(PCT)) and clinical trials. SciClips data extraction and mining team is comprised of [...]
Recent Comments